Markets:

Overview

News

Currencies

International

Treasuries

Agenus Inc. - Common Stock (NQ:AGEN)

3.325 -0.175 (-5.00%)

Streaming Delayed Price Updated: 11:09 AM EDT, Jul 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Agenus Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Agenus Presents Positive Efficacy and Safety Outcomes for AGEN2373 at ASCO

June 05, 2023

From Agenus Inc.

Via Business Wire

Agenus Announces Virtual Annual Shareholders Meeting

June 05, 2023

From Agenus

Via Business Wire

Agenus to Participate in Jefferies Healthcare Conference

May 25, 2023

From Agenus

Via Business Wire

Agenus (AGEN) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

AGEN earnings call for the period ending March 31, 2023.

Via The Motley Fool

Agenus' Investigational Cancer Combo Therapy Shows 33% Durable Responses In Ovarian Cancer ↗

March 27, 2023

Via Benzinga

Why Agenus Stock Is Slumping This Week ↗

March 23, 2023

The biotech may have to raise capital soon.

Via The Motley Fool

Agenus (AGEN) Q4 2022 Earnings Call Transcript ↗

March 14, 2023

AGEN earnings call for the period ending December 31, 2022.

Via The Motley Fool

Agenus Provides Corporate Update and First Quarter 2023 Financial Results

May 09, 2023

From Agenus Inc.

Via Business Wire

Agenus Selected for Late-Breaking Oral Presentation at ESMO-GI

May 03, 2023

From Agenus

Via Business Wire

Agenus (NASDAQ: AGEN) Featured in Coverage of the Inaugural EF Hutton Global Conference

May 02, 2023

Via Investor Brand Network

Agenus to Present at the American Society of Clinical Oncology 2023 Annual Meeting

April 26, 2023

From Agenus

Via Business Wire

Earnings Preview For Agenus ↗

March 13, 2023

Via Benzinga

Agenus to Provide Corporate Update and First Quarter 2023 Financial Report

April 25, 2023

From Agenus

Via Business Wire

Agenus to Participate in May Investor Conferences

April 24, 2023

From Agenus

Via Business Wire

These 3 Nasdaq Stocks Are on Fire Today: Here's Why ↗

April 17, 2023

A high-dollar buyout is lighting a fire underneath these three Nasdaq stocks today.

Via The Motley Fool

Agenus Receives Fast Track Designation for Botensilimab and Balstilimab in Colorectal Cancer

April 17, 2023

From Agenus Inc.

Via Business Wire

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Gain Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer

April 12, 2023

From Gain Therapeutics, Inc.

Via GlobeNewswire

Why Agenus, Amarin, and Axsome Therapeutics Shares Slumped Today ↗

April 04, 2023

Macro headwinds are weighing on risk-laden biotech stocks today.

Via The Motley Fool

Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics

March 30, 2023

From Agenus Inc.

Via Business Wire

Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer

March 27, 2023

From Agenus Inc.

Via Business Wire

Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives

March 14, 2023

From Agenus Inc.

Via GlobeNewswire

Illumina, Seagen And Other Big Stocks Moving Higher On Monday ↗

March 13, 2023

U.S. stocks traded slightly lower, with the Nasdaq Composite dropping around 0.2% on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Agenus Cancels Conference Call to Discuss the Company’s Minority Cash Holdings at SVB in Light of Government’s SVB Deposit Access Announcement

March 12, 2023

Conference Call Cancelled

From Agenus Inc.

Via GlobeNewswire

Agenus Schedules Conference Call to Discuss the Company’s Minority Cash Holdings at SVB

March 11, 2023

Conference Call on Monday, March 13, 2023 at 8:30 a.m. ET

From Agenus Inc.

Via GlobeNewswire

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2022 Financial Report

February 28, 2023

Conference Call on Tuesday, March 14, 2023 at 8:30 a.m. ET

From Agenus Inc.

Via GlobeNewswire

Agenus to Present Botensilimab Data in Oral Plenary Session at the Society of Gynecologic Oncology 2023 Annual Meeting on Women’s Cancer

February 28, 2023

From Agenus Inc.

Via GlobeNewswire

Agenus to Participate in February Investor Conferences

January 26, 2023

From Agenus Inc.

Via GlobeNewswire

Agenus Presents Clinical Data Demonstrating Durable Responses For Colorectal Cancer Candidate ↗

January 23, 2023

Via Benzinga

Agenus Presents Clinical Data Demonstrating Durable Responses of Botensilimab/Balstilimab Combination in Metastatic Microsatellite Stable Colorectal Cancer at ASCO GI

January 23, 2023

From Agenus Inc.

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.